ACS Trials

Make sense of the alphabet soup of trials in Acute Coronary Syndrome; download ACS Trials today. for iphone and ipad.

[Saint Luke's @saintlukeskc]

Carecubes are isolation tents that make it safe for infectious disease patients to have physical contact with their care team and visitors, including hugging. @MidAmericaHeart and @MichaelNassifMD recently participated in the successful trial at Saint Luke's. #ThePowerOfResearch

[Michael Nassif @MichaelNassifMD]

Curious if structural/interventionalists have encountered anything like this.

Pleasant 60 yo, has 4 surgical AVRs over the past 40 years, last one done 12/2018 left an iatrogenic VSD just below the valve (all posted with patient permission). 1/8

[Michael Nassif @MichaelNassifMD]

I have had a few requests for Missouri in depth COVID stats. I have hesitated, as Missouri is a bit complex to analyze for a couple of reasons.... 1/6

[Michael Nassif @MichaelNassifMD]

So overall you might conclude Missouri hasn’t really flattened the curve (with stable relative increase in daily cases and rising positive test rate). BUT if you look at the individual metros it’s a tale of two cities (metros in this instance).

[Michael Nassif @MichaelNassifMD]

Nice essay by @rs_gc about the anxiety of facing an unknown enemy. God speed to us all. https://t.co/y8MjACL6aE

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

We are transitioning to exclusively virtual visits for stable pts tomorrow. Physicians not familiar with the virtual interface are being trained tonight. All of this is designed to further reduce exposure to patients and health care professionals, and help to #FlattenTheCurve.

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Darius was singing the National Anthem at the @NCAA @FinalFour last year as a student @KUHoops. This year, he was diagnosed with acute #HeartFailure that ultimately led to #HeartTransplant at @MidAmericaHeart @saintlukeskc. What a great story! Go Darius!

https://t.co/421MwdtnT1

[ACS Trials @ACSTrials]

@drjohnm @EJSMD for the non EPs, how clinically relevant is “noise/low impedance” in leads?

[Brett Sperry, MD @BrettSperryMD]

@jtsaxon explaining what cheetos have to do with #Cardiotwitter at @saintlukeskc #MAHI educational conference

[Brett Sperry, MD @BrettSperryMD]

Honored to be a part of this storied heart transplant program! @MagalskiAnthony @ACSTrials

[ACS Trials @ACSTrials]

@heartdoc45 @jtsaxon Seems more consistent with the good advice that you just didn't take.

[ACS Trials @ACSTrials]

@ajaykirtane @califf001 I believe @JAG24851 has a ESPN style 30 second highlight clip of this debacle.

[John T. Saxon, MD @jtsaxon]

#CardioTwitter is in need of a mandatory viewing of #Ratatouille @smallratchef. Creators and critics are both important; there wouldn’t be a movie without both. In the end, they find common ground. Waiting for us all to get to that final scene.

[ACS Trials @ACSTrials]

Quite a sensational headline for a state which the CDC lists 0.1 cases of lyme per 100,000 people. https://t.co/PURJrxh7nU "Metro researchers combating local Lyme Disease spread while patients cry for more assistance" https://t.co/ZhSV7JSd3D via @seanfox4kc

[ACS Trials @ACSTrials]

@megtirrell @PowerLunch How many victory laps did he run, and how many random objects did he spike onto the ground when he saw the top line?

[ACS Trials @ACSTrials]

@HarryDauerman @HeartBobH @GreggWStone @SVRaoMD Many (myself included) would have suspected the benefit was being overestimated had a relatively small trial been stopped early. Also finding out mortality benefit is very important for adoption.

[ACS Trials @ACSTrials]

@drjohnm Cant explain it all, but weird that they don’t have the baseline medical therapy in table 1 but in the supplement. 13% less acei/arb/arni use in the control arm was significantly different.

[ACS Trials @ACSTrials]

@rwyeh the big question is why not blind the adjudicators??? In trials I’m involved with it isn’t expensive or difficult.

[Brett Sperry, MD @BrettSperryMD]

1/
As #ESCCongress nears, I thought I would do a #tweetorial on amyloidosis. Exciting times for the field and new data/treatments expected next week.

#FITSurvivalGuide #CardioTwitter @tony_breu @rodney_falk @marthagrogan1 @amyloidosisfdn @AmyloidosisSupp @Amyloidosis_ARC

[Ryan P. Daly, MD @DrRyanPDaly]

The time has come to “Bell the Cat” GLP1-RA and SGLT2i reduce cv mortality. We need to take a central role in rx patients to reduce CV risk and improve outcomes. #SCCT2018 https://t.co/7pdsU89CMP